Respiratory failure in oxygen-induced lung disease. A study of survival, development of hypoxemia, and response to benzolamide.
D000138:Acidosis / Q000209:etiology; D000818:Animals; D000831:Animals, Newborn; D002245:Carbon Dioxide / Q000097:blood; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D004195:Disease Models, Animal; D005260:Female; D006935:Hypercapnia / Q000209:etiology; D006985:Hyperventilation / Q000209:etiology; D000860:Hypoxia / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D010100:Oxygen / Q000097:blood / Q000633:toxicity*; D001261:Pulmonary Atelectasis / Q000209:etiology; D011654:Pulmonary Edema / Q000209:etiology; D051381:Rats; D012131:Respiratory Insufficiency / Q000150:complications / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D013449:Sulfonamides / Q000627:therapeutic use*; D013830:Thiadiazoles / Q000627:therapeutic use*; D013997:Time Factors
D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D013830:Thiadiazoles; D002245:Carbon Dioxide; D010100:Oxygen